Latest Headlines

  1. Packaging And Process Equipment Auction Announced 7/7/2025

    Are you looking to upgrade your packaging line or start a new one without breaking the bank? Don’t miss the Proxio Group – “Processing & Packaging Equipment for Multiple Industrial Applications” auction hosted on BidSpotter, with lots closing July 23, 2025, at 10:30 am ET in Cleveland, OH.

  2. InQuest Science Seeking Business Development Executive To Promote Software Technologies 7/3/2025

    Actively looking for an energetic, self starter to lead our outside sales team for our software company, specializing in the visual inspection industry. Identifying and securing new customers leads in a growing industry. We’re looking for a results-driven sales representative to actively seek out and engage customer prospects.

  3. Riverarch Equity Partners Announce Acquisition Of Alconox By Portfolio Company TCP Analytical 7/3/2025

    Riverarch Equity Partners (“Riverarch”) and other investors, including Audax Strategic Capital, The Hillman Company, Lacy Diversified, and PPM America, together with their portfolio company TCP Analytical are pleased to announce the acquisition of Alconox, LLC (“Alconox” or the “Company”), a leading provider of branded laboratory cleaning solutions.

  4. CAI And ValGenesis Partner To Deliver AI-Enabled Digital Validation For The Life Sciences Industry 7/1/2025

    CAI, a global professional services firm specializing in operational readiness for regulated industries, today announced a strategic partnership with ValGenesis, Inc., a leader in digital validation lifecycle management. Together, the companies will help life sciences organizations modernize validation processes and improve compliance through the power of artificial intelligence. 

  5. Lab Oversupply Is Pushing Leasing, Rent and Relocation Down 7/1/2025

    The landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.

  6. Blue Mountain Launches Spring 2025 RAM Release, Advancing Asset Management For Life Sciences 6/25/2025

    Blue Mountain, the leader in GMP-compliant Enterprise Asset Management (EAM) software for life sciences, announces the launch of its Spring 2025 RAM Release, introducing advanced capabilities that drive operational excellence, maximize compliance, and empower mobile teams across the Life Sciences industry. 

  7. AGC Biologics Expands Cell Therapy Development Operations To Asia To Serve Growing Market Need 6/25/2025

    Today, we announced we will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical Center, marking the latest step in the global expansion of the company’s Global Cell and Gene Technologies Division. The improved geographical footprint allows AGC Biologics to better serve customers requiring autologous and allogeneic products across all markets, with cell therapy manufacturing now available in three continents (Milan, Italy – Longmont, Colorado, U.S. – Yokohama, Japan).  

  8. CRDMO Aragen Completes Facility And Equipment Qualification; First GMP batches In Late July 2025 6/20/2025

    Aragen, a leading contract research, development and manufacturing organization (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025. Aragen has successfully completed the facility and equipment qualification and demonstrated the productivity of its intensified fed batch cell culture manufacturing platform to deliver titers >25 g/L.

  9. Leading European Biologics CDMO Mabion, Releases First Batch Of Novalgen's Next-Generation T-Cell Engager, NVG-222 For First In-Human Clinical Trials 6/17/2025

    In a significant move to accelerate the global fight against blood cancers and hard-totreat solid tumours, renowned end-to-end biologics CDMO Mabion have entered into a strategic development and manufacturing partnership with London based NovalGen an existing client with whom cooperation under CDMO orders was first disclosed in current report No. 13/2024 dated August 16, 2024.

  10. Mabion Launches €500,000 Services Contest To Support Next-Gen Oncology Breakthroughs 6/17/2025

    Mabion, a leading biotech-focused CDMO offering end-to-end services, has announced the launch of a €500,000 oncology services contest at BIO International Convention 2025, aimed at accelerating the development of, recombinant protein-based cancer therapies.